KIN Past Earnings image   This KIN past earnings page last updated 9/22/2021
KIN Past Earnings
Data adjusted for KIN split history

PeriodPast Earnings DateGAAP
Q2 20218/5/2021-0.200
Q1 20215/11/2021-0.240
Q4 20203/16/2021-0.280
Q3 202011/9/2020-0.310
Q2 20208/5/20200.600
Q1 20205/7/2020-0.450
Q4 20193/16/2020-0.400
Q3 201911/12/2019-0.390
Q2 20198/1/2019-0.370
Q1 20195/9/2019-0.420
Q4 20183/6/2019-0.46
Q3 201811/7/2018-0.39
Q2 20188/9/2018-0.39
Q1 20185/8/2018-0.36
Q4 20173/1/2018-0.35
Q3 201711/7/2017-0.29
Q2 20178/7/2017-0.29
Q1 20175/3/2017-0.3
Q4 20163/1/2017-0.29
Q3 201611/7/2016-0.29
Q2 20168/8/2016-0.25
Q1 20165/5/2016-0.31
Q4 20153/2/2016-0.32
Q3 201511/9/2015-0.36
Q2 20158/10/2015-0.35
Q1 20155/8/2015-0.34
Q4 20143/12/2015-0.34
Q3 201411/13/2014-0.31
Q2 20148/13/2014-0.42
Q1 20145/12/2014-0.38
KIN Past Revenue
PeriodPast Earnings DateGAAP
Q2 20218/5/20210.00B
Q1 20215/11/20210.00B
Q4 20203/16/20210.00B
Q3 202011/9/20200.00B
Q2 20208/5/20200.04B
Q1 20205/7/20200.00B
Q4 20193/16/20200.00B
Q3 201911/12/20190.00B
Q2 20198/1/20190.00B
Q1 20195/9/20190.00B
Q4 20183/6/20191.33M
Q3 201811/7/2018640000
Q2 20188/9/2018NA
Q1 20185/8/2018NA
Q4 20173/1/2018NA
Q3 201711/7/2017NA
Q2 20178/7/2017NA
Q1 20175/3/2017NA
Q4 20163/1/2017NA
Q3 201611/7/2016NA
Q2 20168/8/2016NA
Q1 20165/5/2016NA
Q4 20153/2/2016NA
Q3 201511/9/2015NA
Q2 20158/10/2015NA
Q1 20155/8/2015NA
Q4 20143/12/2015NA
Q3 201411/13/2014NA
Q2 20148/13/2014NA
Q1 20145/12/2014NA
Quotes delayed 20 minutes
Get Free SEC filing alerts for KIN:
KIN SEC Filing Email Alerts ServiceExternal link
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Kindred Biosciences (KIN) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

KMPH Historical Earnings
KPTI Historical Earnings
KRYS Historical Earnings
KURA Historical Earnings
LCI Historical Earnings
LGND Historical Earnings
LH Historical Earnings
LHCG Historical Earnings
LIFE Historical Earnings
LJPC Historical Earnings
On this page we presented the KIN past earnings date information for Kindred Biosciences. Reviewing that KIN Past Earnings for the company, we see that the highest past earnings result in our data set was in Q2 2020, when KIN posted gaap of 0.600/share. Meanwhile the lowest KIN past earnings result was in Q4 2018, when KIN posted gaap of -0.46/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2020 when KIN reported 0.04B in revenue, while the smallest revenue quarter was Q2 2018 when KIN reported NA in revenue.

Any self directed investor doing their due diligence on KIN or any other given stock can benefit from researching all of the Kindred Biosciences past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Kindred Biosciences past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for KIN. Thanks for visiting, and the next time you need to research KIN past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.
 

KIN Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2021, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.